Visit the SeeTreat booth at ESTRO 2025 where we will be introducing our ART.1 product with on-booth presentations from Prof Paul Keall and A/Prof Jarad Martin.
In this study, we have developed a robust synthetic CT (sCT) generation method via DIR for patients with HNC. Our method met the AAPM Task Group 132 guidelines, with the TRE below the maximum voxel dimension (3 mm).
An in silica characterisation of a real-time prostate cancer GDoF IGRT system for conventional linear accelerators has demonstrated high geometric fidelity and low computational latency.
Prof. Paul Keall discusses a game-changing approach to making offline adaptive evaluation more accessible to everyone. This is a unique opportunity to learn from a global leader in radiation oncology research and watch the live Q&A session following the presentation.